Podcast on the Management of Adverse Events Associated with Lorlatinib Todd M. BauerErin M. Bertino Commentary Open access 11 February 2022 Pages: 1447 - 1456
Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic Monica FletcherThys van der MolenEmilio Pizzichini Commentary Open access 14 February 2022 Pages: 1457 - 1473
The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia Valeria SantiniMichael LübbertGert J. Ossenkoppele Review Open access 16 November 2021 Pages: 1474 - 1488
Correction to: The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia Valeria SantiniMichael LübbertGert J. Ossenkoppele Correction 15 February 2022 Pages: 1489 - 1489
Treatment Failure in Axial Spondyloarthritis: Insights for a Standardized Definition Xavier JuanolaManuel J. Moreno RamosJordi Gratacós Review Open access 24 February 2022 Pages: 1490 - 1501
Managing Cachexia in Head and Neck Cancer: a Systematic Scoping Review Antti A. MäkitieRasheed Omobolaji AlabiAlfio Ferlito Review Open access 27 February 2022 Pages: 1502 - 1523
Therapeutic Advances in Viral Hepatitis A–E Navroop NagraRichard A. KozarekBlaire E. Burman Review 27 February 2022 Pages: 1524 - 1552
Impact of Depression Onset and Treatment on the Trend of Annual Medical Costs in Japan: An Exploratory, Descriptive Analysis of Employer-Based Health Insurance Claims Data Yoshinori ChoIzumi MishiroTadashi Nakajima Original Research Open access 02 November 2021 Pages: 1553 - 1566
Correction to: Impact of Depression Onset and Treatment on the Trend of Annual Medical Costs in Japan: An Exploratory, Descriptive Analysis of Employer-Based Health Insurance Claims Data Yoshinori ChoIzumi MishiroTadashi Nakajima Correction 07 February 2022 Pages: 1567 - 1567
The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens Bo JiangLin GaoDawei Sun Original Research Open access 24 November 2021 Pages: 1568 - 1581
Evaluation of Patient-Reported Satisfaction and Clinical Efficacy of Once-Weekly Semaglutide in Patients with Type 2 Diabetes: An Ambispective Study Ayman A. Al HayekMohamed A. Al Dawish Original Research 04 February 2022 Pages: 1582 - 1595
Single-Center Experience with Trabectedin for the Treatment of Non-L-sarcomas Paula Cerdà SerdàRaúl TerésAntonio López-Pousa Original Research 07 February 2022 Pages: 1596 - 1610
Correction to: The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens Bo JiangLin GaoDawei Sun Correction 12 February 2022 Pages: 1611 - 1611
A Feasibility Study: Testing Whether a Sleep Application Providing Objective Sleep Data to Physicians Improves Patient–Physician Communication Regarding Sleep Experiences, Habits, and Behaviors Sana DurraniSha CaoBabar Khan Original Research Open access 08 February 2022 Pages: 1612 - 1629
Risk Factor Analysis of the Conservative Treatment in Chronic Subdural Hematomas: A Substudy of the ATOCH Trial Dong WangYe TianRongcai Jiang Original Research 08 February 2022 Pages: 1630 - 1641
Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus: A Post-Marketing Surveillance in Japan Takashi KadowakiNobuya InagakiTatsuki Teranishi Original Research Open access 09 February 2022 Pages: 1642 - 1658
Long-Term Intraocular Pressure-Lowering Effects and Adverse Events of Ripasudil in Patients with Glaucoma or Ocular Hypertension over 24 Months Hidenobu TaniharaTakahiko KakudaYuji Kurihara Original Research Open access 12 February 2022 Pages: 1659 - 1677
A Matching-Adjusted Indirect Comparison of Single-Arm Trials in Patients with Relapsed or Refractory Follicular Lymphoma Who Received at Least Two Prior Systemic Treatments: Tazemetostat was Associated with a Lower Risk for Safety Outcomes Versus the PI3-Kinase Inhibitors Idelalisib, Duvelisib, Copanlisib, and Umbralisib David ProudmanDave NellesenKhalid Mamlouk Original Research Open access 14 February 2022 Pages: 1678 - 1696
Phase 1b/3 Pharmacokinetics and Safety Study of Intravenous Posaconazole in Adult Asian Participants at High Risk for Invasive Fungal Infections Depei WuYingchang MiLianzhe Xu Original Research Open access 15 February 2022 Pages: 1697 - 1710
Evaluation of Cognitive Deficits in Adults with Type 1 Diabetes Stratified by the Age of Diabetes Onset: A Cross-Sectional Study Vinay DograBhavika MittalNikhil Tandon Original Research 19 February 2022 Pages: 1711 - 1723
Comparison of Inconvenience Costs Between Influenza Antivirals for Japanese Pediatric Patients: A Conjoint Analysis of Parental Responses Kenji KurazonoHidetoshi IkeokaDaisuke Tamura Original Research Open access 21 February 2022 Pages: 1724 - 1742
Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers Ana CasajúsPablo ZubiaurFrancisco Abad-Santos Original Research Open access 22 February 2022 Pages: 1743 - 1753
Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting Brooke HarrowFrancis FagnaniLouis de Mestier Original Research Open access 22 February 2022 Pages: 1754 - 1771
Understanding the Patient Experience of Hunger and Improved Quality of Life with Setmelanotide Treatment in POMC and LEPR Deficiencies Martin WabitschSheri FehnelPeter Kühnen Original Research Open access 22 February 2022 Pages: 1772 - 1783
Defining Utility Values for Chorea Health States in Patients with Huntington’s Disease Daniel O. ClaassenRajeev AyyagariRinat Ribalov Original Research Open access 23 February 2022 Pages: 1784 - 1793
Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis Amy L. OlsonNadine HartmannLaura Wallace Original Research Open access 23 February 2022 Pages: 1794 - 1809
Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study Sibyl WrayFlorian Then BerghBarry A. Singer Original Research Open access 24 February 2022 Pages: 1810 - 1831
Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction Marco Antonio Scanavini-FilhoOtavio BerwangerJosé C. Nicolau Original Research Open access 26 February 2022 Pages: 1832 - 1843
Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands Erik H. SernéStéphane RozeHarold W. de Valk Original Research 28 February 2022 Pages: 1844 - 1856
A Case Series Assessing the Effects of Lomitapide on Carotid Intima-Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting Dirk J. BlomDaniel GaudetLuis Masana Marin Case Series Open access 23 February 2022 Pages: 1857 - 1870
